Vladimir R. Muzykantov

California University of Pennsylvania — United States

Materials Science · Physical Sciences

79h-index20.7kcitations372works12.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(66), Monoclonal and Polyclonal Antibodies Research(49), Erythrocyte Function and Pathophysiology(48), Blood Coagulation and Thrombosis Mechanisms(43), Blood properties and coagulation(43)

Publications372 total

Decoupling Physisorption from Chemisorption in Clickable Lipid Nanoparticles
ACS Nanoscience Au·2026Open Access
Targeting DNA‐LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity
Advanced Science·2026· 1 citedOpen Access
Equip your vehicle for the right terrain: Using features of local pathology to guide engineering of targeted drug delivery systems
Journal of Controlled Release·2025· 1 citedOpen Access
Abstract 4362907: Inhibition of Fibrin Formation by the GPRP–Dextran Conjugate: A New Approach to Safe Anticoagulation
Circulation·2025
Tropomyosin 1 promotes platelet adhesion and clot contraction to inhibit thrombosis
Blood·2025Open Access
Inside Fibrin Clots Red Blood Cell Aggregation Induces Platelet-Independent Clot Contraction
Journal of Thrombosis and Haemostasis·2025
Modeling Fibrosis with MASH Patient Liver-Derived Organoids
2025Open Access
Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape
Nature Nanotechnology·2025· 28 citedOpen Access
Tropomyosin 1 promotes platelet adhesion and clot contraction separate from its roles in developmental hematopoiesis
2025Open Access
Targeting Porcine Liver Endothelium with Lipid Nanoparticles to Improve Xenograft Survival
American Journal of Transplantation·2025
Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo
Proceedings of the National Academy of Sciences·2025· 7 citedOpen Access
Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity
2025· 1 citedOpen Access
VCAM-Targeted Nanocarriers: Transforming the Brain's Vasculature into a Therapeutic Biofactory
Neurotherapeutics·2025Open Access
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications
Nature Nanotechnology·2025· 22 cited
A percolation phase transition controls complement protein coating of surfaces
Cell·2025· 5 citedOpen Access
Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage
Blood Advances·2025· 7 citedOpen Access
CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery
Molecular Therapy·2025· 17 citedOpen Access
Core-Then-Shell Lipid Nanoparticles for Next Generation Nucleic Acid Delivery: Improving Gene Delivery by Enhanced DNA Encapsulation (Abstract ID: 158560)
Journal of Pharmacology and Experimental Therapeutics·2025
Abstract TP368: Targeted Lipid Nanoparticles to Modulate Blood-Brain Barrier Transcytosis in Acute Ischemic Stroke
Stroke·2025
Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation
Advanced Materials·2024· 28 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Vladimir V. Shuvaev(12), Silvia Muro(11), Samir Mitragotri(10), Nagarajan Kandasamy(8), Jacob W. Myerson(7), Raisa Y. Kiseleva(7), Hamideh Parhiz(6), Aaron C. Anselmo(5), Blaine J. Zern(5), Daniel C. Pan(5), Elizabeth D. Hood(5), Aron B. Fisher(5), Thomas D. Dziubla(5), Oscar A. Marcos‐Contreras(4), Priyal Patel(4), Makan Khoshnejad(4), Steven Μ. Albelda(4), Michael Koval(4), Norbert Pardi(4), Eric Simone(4)